uric acid has been researched along with End Stage Liver Disease in 1 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
End Stage Liver Disease: Final stage of a liver disease when the liver failure is irreversible and LIVER TRANSPLANTATION is needed.
Excerpt | Relevance | Reference |
---|---|---|
"WIT and post-LT hyperuricemia are associated with the prevalence of PTMS." | 5.48 | Warm ischemia time and elevated serum uric acid are associated with metabolic syndrome after liver transplantation with donation after cardiac death. ( Chai, YC; Hu, LS; Jia, A; Lv, Y; Shi, JH; Tian, M; Wang, B; Zhang, C; Zheng, J, 2018) |
"WIT and post-LT hyperuricemia are associated with the prevalence of PTMS." | 1.48 | Warm ischemia time and elevated serum uric acid are associated with metabolic syndrome after liver transplantation with donation after cardiac death. ( Chai, YC; Hu, LS; Jia, A; Lv, Y; Shi, JH; Tian, M; Wang, B; Zhang, C; Zheng, J, 2018) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hu, LS | 1 |
Chai, YC | 1 |
Zheng, J | 1 |
Shi, JH | 1 |
Zhang, C | 1 |
Tian, M | 1 |
Lv, Y | 1 |
Wang, B | 1 |
Jia, A | 1 |
1 other study available for uric acid and End Stage Liver Disease
Article | Year |
---|---|
Warm ischemia time and elevated serum uric acid are associated with metabolic syndrome after liver transplantation with donation after cardiac death.
Topics: Adult; Biomarkers; Donor Selection; End Stage Liver Disease; Female; Follow-Up Studies; Humans; Hype | 2018 |